Hazard Information | Back Directory | [Uses]
Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research[1]. | [References]
[1] Meininger V, et al. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017 Mar;16(3):208-216. DOI:10.1016/S1474-4422(16)30399-4 |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 |
Website: |
www.biolabreagent.com/ |
|